| Hans-Günter Meyer-Thompson | Monatliche Neuheiten
EMA Expands Access to Opioid Overdose Treatment
EMA Expands Access to Opioid Overdose Treatment
At its October 2026 meeting, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) recommended reclassifying Nyxoid (naloxone, Mundipharma Corporation Ltd) nasal spray as an over-the-counter medication. (Medsape, USA, 19.10.2026)
https://www.medscape.com/viewarticle/ema-expands-access-opioid-overdose-treatment-2026a100138y